BB Biotech AG
BION
Rang in aandelen
#4524
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG.... BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
Aandeelprijs
$60.68
Marktkapitalisatie
$3.35B
Verandering (1 dag)
-0.79%
Verandering (1 jaar)
23.99%
Land
CH
Handel BB Biotech AG (BION)
Categorie
Financial Services
Koersgeschiedenis voor BB Biotech AG (BION)
Hoogste slotkoers: $63.78 op 2026-10-01
Laagste slotkoers: $15.30 op 2000-01-01
Laagste slotkoers: $15.30 op 2000-01-01
Koersgeschiedenis van BB Biotech AG van 2000 tot 2026
Jaarlijkse koersprestatie
| Jaar | Prestaties |
|---|---|
| 2026 (TTM) | 6.35% |
| 2025 | 38.69% |
| 2024 | -11.18% |
| 2023 | -24.95% |
| 2022 | -25.80% |
| 2021 | 2.69% |
| 2020 | 17.40% |
| 2019 | 11.01% |
| 2018 | -6.61% |
| 2017 | 23.80% |
| 2016 | -7.89% |
| 2015 | 22.59% |
| 2014 | 52.76% |
| 2013 | 62.77% |
| 2012 | 49.65% |
| 2011 | 1.37% |
| 2010 | -14.60% |
| 2009 | 29.73% |
| 2008 | -26.26% |
| 2007 | 3.29% |
| 2006 | 23.76% |
| 2005 | 1.84% |
| 2004 | 19.32% |
| 2003 | 21.32% |
| 2002 | -43.88% |
| 2001 | -30.37% |
| 2000 | 0.00% |
Aandelenkoers van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aandelenkoers | Verandering 1jr% | Land |
|---|---|---|---|
| $1.14K | 1.09% |
US
|
|
| $116.56 | -27.92% |
US
|
|
| $40.87 | 23.58% |
SE
|
|
| $92.62 | -24.88% |
US
|
|
| $47.26 | -12.47% |
US
|
